Polydatin, a natural precursor of resveratrol, induces cell cycle arrest and differentiation of human colorectal Caco-2 cell

Journal of Translational Medicine

Paola Stiuso²  Gianpietro Ravagnan⁴  Maria Cartenì⁵  Michele Caraglia²  Nicola Amodio³  Angela Lombardi²  Ilaria Scognamiglio²  Salvatore De Maria¹ 

[1] Institute “Massimo D’Azeglio”, Marano di Napoli, Naples 80016, Italy;Department of Biochemistry, Biophisics and General Pathology, Second University of Naples, Naples, Italy;Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy;Department of Molecular Sciences and Nanosystems, Ca’ Foscari Venezia University, Venice, Italy;Operative Unit of Naples GLURES, Academic SPIN-OFF of Ca’ Foscari University of Venice, Venice, Italy

关键词: Differentiation;    hsp27;    Human colon carcinoma;   

Others  :  824996
DOI  :  10.1186/1479-5876-11-264

 received in 2013-07-23, accepted in 2013-10-08,  发布年份 2013

【 摘 要 】

Background

Human colon adenocarcinoma cells are resistant to chemotherapeutic agents, such as anthracyclines, that induce death by increasing the reactive oxygen species. A number of studies have been focused on chemo-preventive use of resveratrol as antioxidant against cardiovascular diseases, aging and cancer. While resveratrol cytotoxic action was due to its pro-oxidant properties. In this study, we investigate whether the Resveratrol (trans-3,5,49-trihydroxystilbene) and its natural precursor Polydatin (resveratrol-3-O-b-mono- D-glucoside, the glycoside form of resveratrol) combination, might have a cooperative antitumor effect on either growing or differentiated human adenocarcinoma colon cancer cells.

Methods

The polydatin and resveratrol pharmacological interaction was evaluated in vitro on growing and differentiated Caco-2 cell lines by median drug effect analysis calculating a combination index with CalcuSyn software. We have selected a synergistic combination and we have evaluated its effect on the biological and molecular mechanisms of cell death.

Results

Simultaneous exposure to polydatin and resveratrol produced synergistic antiproliferative effects compared with single compound treatment. We demonstrated that polydatin alone or in combination with resveratrol at 3:1 molar ratio synergistically modulated oxidative stress, cell cycle, differentiation and apoptosis. Worthy of note treatment with polydatin induced a nuclear localization and decreased expression of heat shock protein 27, and vimentin redistributed within the cell.

Conclusions

From morphological, and biochemical outcome we obtained evidences that polydatin induced a transition from a proliferative morphology to cell-specific differentiated structures and caused human CaCo-2 cell death by induction of apoptosis. Our data suggest the potential use of polydatin in combination chemotherapy for human colon cancer.

【 授权许可】

   
2013 De Maria et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Bamia C, Lagiou P, Buckland G, Grioni S, Agnoli C, Taylor AJ, Dahm CC, et al.: Mediterranean diet and colorectal cancer risk: results from a European cohort. Eur J Epidemiol 2013. [Epub ahead of print] PubMed PMID: 23579425
• [2]Hu F, Li D, Wang Y, Yao X, Zhang W, Liang J, Lin C, Ren J, Zhu L, Wu Z, Li S, et al.: Novel DNA variants and mutation frequencies of hMLH1 and hMSH2 genes in colorectal cancer in the northeast china population. PLoS One 2013, 8(4):e60233. doi: 10.1371/journal.pone.0060233. Epub2013 Apr 3. PubMed PMID: 23573243; PubMed Central PMCID: PMC3616036
• [3]Zhu C, Bassig BA, Zaridze D, Boyle P, Dai M, Li Q, Zheng T: A birth cohort analysis of the incidence of ascending and descending colon cancer in the United States, 1973–2008. Cancer Causes Control 2013. Epub ahead of print] PubMed PMID: 23535866
• [4]Jolly C, Morimoto RI: Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 2000, 92(19):1564-1572. Review. PubMed PMID: 11018092
• [5]Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR: Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 2006, 31(3):164-172. Epub 2006 Feb 17. Review. PubMed PMID: 1648378
• [6]Manson MM, Farmer PB, Gescher A, Steward WP: Innovative agents in cancer prevention, Recent results in cancer research. Fortschritte der Krebsforschung 2005, 166:257-275.
• [7]Zamora-Ros R, Andres-Lacueva C, Lamuela-Raventós RM, Berenguer T, Jakszyn P, Martínez C, Sánchez MJ, Navarro C, Chirlaque MD, Tormo MJ, Quirós JR, Amiano P, Dorronsoro M, Larrañaga N, Barricarte A, Ardanaz E, González CA: Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a spanish population: European prospective investigation into cancer and nutrition (EPIC)-spain cohort. Br J Nutr 2008, 100(1):188-196. Epub 2007 Dec 21. PubMed PMID: 18096094
• [8]Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Förstermann U: Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002, 106(13):1652-1658.
• [9]Russell J, Okayama N, Alexander JS, Granger DN, Hsia CJ: Pretreatment with polynitroxyl albumin (PNA) inhibits ischemia-reperfusion induced leukocyte-endothelial cell adhesion. Free Radic Biol Med 1998, 25(2):153-159.
• [10]Thom SR, Bhopale VM, Milovanova TN, Yang M, Bogush M, Buerk DG: Nitric-oxide synthase-2 linkage to focal adhesion kinase in neutrophils influences enzyme activity and β2 integrin function. J Biol Chem 2013, 288(7):4810-4818.
• [11]Magrone T, Jirillo E: The interplay between the gut immune system and microbiota in health and disease: nutraceutical intervention for restoring intestinal homeostasis. Curr Pharm Des 2013, 19(7):1329-1342.
• [12]Shaked H, Hofseth LJ, Chumanevich A, Chumanevich AA, Wang J, Wang Y, Taniguchi K, Guma M, Shenouda S, Clevers H, Harris CC, Karin M: Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation. Proc Natl Acad Sci USA 2012, 109(35):14007-14012. doi: 10.1073/pnas.1211509109. Epub 2012 Aug 14
• [13]Miki K, Kumar A, Yang R, Killeen ME, Delude RL: Extracellular activation of arginase-1 decreases enterocyte inducible nitric oxide synthase activity during systemic inflammation. Am J Physiol Gastrointest Liver Physiol 2009, 297(4):G840-G848. doi: 10.1152/ajpgi.90716.2008. Epub 2009 Aug 27
• [14]Keklikoglu N, Koray M, Kocaelli H, Akinci S: iNOS expression in oral and gastrointestinal tract mucosa. Dig Dis Sci 2008, 53(6):1437-1442.
• [15]Barbieri A, Palma G, Rosati A, Giudice A, Falco A, Petrillo A, Petrillo M, Bimonte S, Di Benedetto M, Esposito G, Stiuso P, Abbruzzese A, Caraglia M, Arra C: " Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth". J Cell Mol Med 2012, 16(4):920-926. doi: 10.1111/j.1582-4934.2011.01375.x
• [16]Washo-Stultz D, Hoglen N, Bernstein H, Bernstein C, Payne CM: Role of nitric oxide and peroxynitrite in bile salt-induced apoptosis: relevance to colon carcinogenesis. Nutr Cancer 1999, 35(2):180-188.
• [17]Saeki M, Kamisaki Y, Maeda S: Involvement of mitogen-activated protein kinase in peroxynitrite-induced cell death of human neuroblastoma SH-SY5Y cells. Neurosci Res 2000, 38(2):213-216.
• [18]Ross GR, Kang M, Akbarali HI: Colonic inflammation alters Src kinase-dependent gating properties of single Ca2+ channels via tyrosine nitration. Am J Physiol Gastrointest Liver Physiol 2010, 298(6):G976-G984.
• [19]Kusaka G, Uno K, Iijima K, Endo H, Asano N, Koike T, Imatani A, Shimosegawa T: The role of nitric oxide in the induction of caudal-type homeobox 2 through epidermal growth factor receptor in the development of Barrett’s esophagus. Scand J Gastroenterol 2012, 47(10):1148-1158. Epub 2012 Jul 27
• [20]Cotter AA, Jewell C, Cashman KD: The effect of oestrogen and dietary phyto-oestrogens on transepithelial calcium transport in human intestinal-like Caco-2 cells. Br J Nutr 2003, 89(6):755-765.
• [21]Kamath AV, Darling IM, Morris ME: Choline uptake in human intestinal Caco-2 cells is carrier-mediated. J Nutr 2003, 133(8):2607-2611.
• [22]Ravagnan G, Falchetti R, Lanzilli G, Fuggetta MP, Tricarico M, Mattivi F: Use of extracts from spermatophyte plants with antitumor activity. PatEP 12923219B1
• [23]Ravagnan G, Falchetti R, Lanzilli G, Fuggetta MP, Tricarico M, Mattivi F: Use of extracts from spermatophyte plants with immunomodulating activity. PatEP 1292320
• [24]Herz F, Schermer A, Halwer M, Bogart LH: Alkaline phosphatase in HT-29, a human colon cancer cell line: influence of sodium butyrate and hyperosmolality. Arch Biochem Biophys 1981, 210(2):581-591.
• [25]Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
• [26]Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982, 126(1):131-138.
• [27]Amodio N, Di Martino MT, Foresta U, et al.: miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis 2012, 3:e436. doi:10.1038/cddis.2012.175
• [28]Chou TC, Talalay P: Quantitative analysis of dose effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984, 22:27-55.
• [29]Ding QM, Ko TC, Evers BM: Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4. Am J Physiol 1998, 275(5 Pt 1):C1193-C1200.
• [30]Morin MJ, Unno N, Hodin RA, et al.: Differential expression of inducible nitric oxide synthase messenger RNA along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats. Crit Care Med 1998, 26:1258-1264.
• [31]Wink DA, Mitchell JB: Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998, 25(4–5):434-456. Review
• [32]Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, et al.: Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000, 2:645-652.
• [33]Bryantsev AL, Loktionova SA, Ilyinskaya OP, Tararak EM, Kampinga HH, Kabakov AE: Distribution, phosphorylation, and activities of Hsp25 in heat-stressed H9c2 myoblasts: a functional link to cytoprotection. Cell Stress Chaperones 2002, 7:146-155.
• [34]Falchetti R, Fuggetta MP, Lanzilli G, Tricarico M, Ravagnan G: Effects of resveratrol on human immune cell function. Life Sci 2001, 70(1):81-96.
• [35]Lanzilli G, Cottarelli A, Nicotera G, Guida S, Ravagnan G, Fuggetta MP: Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation 2012, 35(1):240-248.
• [36]Fuggetta MP, D’Atri S, Lanzilli G, Tricarico M, Cannavò E, Zambruno G, Falchetti R, Ravagnan G: In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. Melanoma Res 2004, 14(3):189-196.
• [37]Lanzilli G, Fuggetta MP, Tricarico M, Cottarelli A, Serafino A, Falchetti RN, Ravagnan G, Turriziani M, Adamo R, Franzese O, Bonmassar E: Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int J Oncol 2006, 28(3):641-648.
• [38]Fuggetta MP, Lanzilli G, Tricarico M, Cottarelli A, Falchetti R, Ravagnan G, Bonmassar E: Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro. J Exp Clin Cancer Res 2006, 25(2):189-193.
• [39]Kovacic P, Somanathan R: “Multifaceted approach to resveratrol bioactivity Focus on antioxidant action, cell signaling and safety”. Oxid Med Cell Longev 2010, 3(2):86-100.
• [40]Fabris S, Momo F, Ravagnan G, Stevanato R: Antioxidant properties of resveratrol and piceid on lipid peroxidation in micelles and monolamellar liposomes. Biophys Chem 2008, 135(1–3):76-83.
• [41]Caraglia M, Giuberti G, Marra M, Addeo R, Montella L, Murolo M, Sperlongano P, Vincenzi B, Naviglio S, Prete SD, Abbruzzese A, Stiuso P: "Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. Cell Death Dis 2006, 20(6):765-773.
• [42]Wenzel U, Kuntz S, Daniel H: Nitric oxide levels in human preneoplastic colonocytes determine their susceptibility toward antineoplastic agents. Mol Pharmacol 2003, 64(6):1494-1502.
• [43]Andersson MC, Tobin G, Giglio D: Cholinergic nitric oxide release from the urinary bladder mucosa in cyclophosphamide-induced cystitis of the anaesthetized rat. Br J Pharmacol 2008, 153(7):1438-1444. doi:10.1038/bjp.2008.6. Epub 2008 Feb 4
• [44]Ronchetti D, Borghi V, Gaitan G, Herrero JF, Impagnatiello F: NCX 2057 2057, a novel NO-releasing derivative of ferulic acid, suppresses inflammatory and nociceptive responses in in vitro and in vivo models. Br J Pharmacol 2009, 158(2):569-579. doi: 10.1111/j.1476-5381.2009.00324.x. Epub 2009 Jul 7
• [45]Kumarapeli AR, Wang X: Genetic modification of the heart: chaperones and the cytoskeleton. J Mol Cell Cardiol 2004, 37(6):1097-1109.
• [46]Koti RS, Seifalian AM, McBride AG, Yang W, Davidson BR: The relationship of hepatic tissue oxygenation with nitric oxide metabolism in ischemic preconditioning of the liver. FASEB J 2002, 16(12):1654-1656.
• [47]Zhu H, Zhang L, Wu S, Teraishi F, Davis J, Jacob D, Fang B: Induction of S-phase arrest and p21 overexpression by a small molecule 2[[3-(2,3-dichlorophenoxy)propyl] amino]ethanol in correlation with activation of ERK. Oncogene 2004, 23:4984-4992.
• [48]O’Sullivan MP, Tyner JW, Holtzman MJ: Apoptosis in the airways: another balancing act in the epithelial program. Am J Respir Cell Mol Biol 2003, 29(1):3-7.
• [49]Amaravadi R, Thompson CB: The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 2005, 115(10):2618-2624.
• [50]Sinha D, Wang Z, Ruchalski KL, Levine JS, Krishnan S, Lieberthal W, Schwartz JH, Borkan SC: Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am J Physiol Renal Physiol 2005, 288(4):703-713. Epub 2004 Nov 30
• [51]Rousset M: The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. Biochimie 1986, 68(9):1035-1040. Review. No abstract available
• [52]Stierum R, Gaspari M, Dommels Y, Ouatas T, Pluk H, Jespersen S, Vogels J, Verhoeckx K, Groten J, van Ommen B: Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2. Biochim Biophys Acta 2003, 1650(1–2):73-91.